Physician profile
Timothy Mills
NPI 1972694628
$5,960.74
in general payments reported to CMS, 2019-2025
45 companies · $990 in 2025
The $990 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $296 · 2021: $1,051 · 2022: $1,162 · 2023: $956 · 2024: $1,210 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,124 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,123.87 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $881.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.24 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Pfizer INC. | $402.93 | 2020-2025 | |
| Abbvie INC. | $393.92 | 2021-2025 | |
| Amarin Pharma, INC. | $391.15 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $385.48 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $307.81 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $282.82 | 2019-2025 | Otezla, Repatha, Otezla |
| Abbott Laboratories | $238.45 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $225.31 | 2019-2024 | Mounjaro, Jardiance, Trulicity |
| Bayer Healthcare Pharmaceuticals INC. | $191.42 | 2022-2025 | |
| Dexcom, INC. | $187.40 | 2024-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $158.40 | 2019-2025 | |
| Exact Sciences Corporation | $151.51 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $141.83 | 2019-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.